Literature DB >> 22781546

Oxidative stress in stable cystic fibrosis patients: do we need higher antioxidant plasma levels?

Antonela Lezo1, Fiorella Biasi, Paola Massarenti, Roberto Calabrese, Giuseppe Poli, Bruna Santini, Elisabetta Bignamini.   

Abstract

UNLABELLED: Oxidative stress plays an important role in cystic fibrosis (CF). However, there is a lack of validated biomarkers of oxidative damage that correlate with the antioxidant needs of patients with CF.
OBJECTIVE: To investigate oxidative stress in stable pediatric CF patients and evaluate if vitamin supplementation may be tailored to individual needs and oxidative status.
RESULTS: Lipid-adducts 4-hydroxynonenal (HNE-L) and malonaldehyde (MDA-L) (chromolipids) were elevated in the majority of patients despite normal plasma vitamin E, A and C. HNE-L and MDA-L increased with age, while plasma vitamins decreased. The most relevant correlation was identified between vitamin C and chromolipids. Patients with pancreatic insufficiency (PI) showed significantly higher plasma chromolipids despite no differences in plasma vitamins.
CONCLUSIONS: The majority of patients showed elevated plasma chromolipids that increased with age. Antioxidant vitamin reference ranges provide incomplete information on the redox status. CF patients with PI showed excessive oxidative stress damage.
Copyright © 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22781546     DOI: 10.1016/j.jcf.2012.06.002

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  7 in total

1.  Links between Disease Severity, Bacterial Infections and Oxidative Stress in Cystic Fibrosis.

Authors:  Sabina Galiniak; Mateusz Mołoń; Marta Rachel
Journal:  Antioxidants (Basel)       Date:  2022-04-29

2.  Sildenafil improves vascular endothelial function in patients with cystic fibrosis.

Authors:  Paula Rodriguez-Miguelez; Nichole Lee; Matthew A Tucker; Gábor Csányi; Kathleen T McKie; Caralee Forseen; Ryan A Harris
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-31       Impact factor: 4.733

Review 3.  Idiosyncratic adverse drug reactions: current concepts.

Authors:  Jack Uetrecht; Dean J Naisbitt
Journal:  Pharmacol Rev       Date:  2013-03-08       Impact factor: 25.468

4.  Systemic oxidative stress in children with cystic fibrosis with bacterial infection including Pseudomonas Aeruginosa.

Authors:  Gabriela Datsch Bennemann; Emilia Addison Machado Moreira; Leticia Cristina Radin Pereira; Maiara Brusco de Freitas; Diane de Oliveira; Julia Carvalho Ventura; Eduardo Benedetti Parisotto; Yara Maria Franco Moreno; Erasmo Benicio Santos Moraes Trindade; Eliana Barbosa; Norberto Ludwig Neto; Danilo Wilhelm Filho
Journal:  Clin Respir J       Date:  2022-06-26       Impact factor: 1.761

Review 5.  Update on the management of vitamins and minerals in cystic fibrosis.

Authors:  Senthilkumar Sankararaman; Sara J Hendrix; Terri Schindler
Journal:  Nutr Clin Pract       Date:  2022-08-23       Impact factor: 3.204

6.  Reactive-oxygen-species-mediated P. aeruginosa killing is functional in human cystic fibrosis macrophages.

Authors:  Noemi Cifani; Barbara Pompili; Marco Anile; Miriam Patella; Daniele Diso; Federico Venuta; Giuseppe Cimino; Serena Quattrucci; Enea Gino Di Domenico; Fiorentina Ascenzioni; Paola Del Porto
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

7.  Oxidative modification of proteins in pediatric cystic fibrosis with bacterial infections.

Authors:  Izabela Sadowska-Bartosz; Sabina Galiniak; Grzegorz Bartosz; Marta Rachel
Journal:  Oxid Med Cell Longev       Date:  2014-04-03       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.